1. Differentiating between micronucleus dose-responses induced by whole cigarette smoke solutions with Benchmark Dose potency ranking.
- Author
-
Mittelstaedt RA, Shaddock JG, Bhalli JA, Guo X, Li Y, Mei N, De M, Richter PA, and Heflich RH
- Subjects
- Animals, Benchmarking methods, Canada, Cell Line, DNA Damage drug effects, Lymphocytes drug effects, Male, Mutagenicity Tests methods, Rats, Rats, Sprague-Dawley, Smoking adverse effects, Smoke adverse effects, Nicotiana toxicity, Tobacco Products toxicity
- Abstract
Dose-response modeling of in vitro micronucleus test (IVMNT) data was evaluated to determine if the approach has value in discriminating among different tobacco products. Micronucleus responses were generated in L5178Y/Tk
+/- mouse lymphoma cells and TK6 human lymphoblastoid cells from a series of whole smoke solutions (WSSs) expected to have different levels of genotoxicity based on differences in their machine-generated smoke constituents. Eight WSSs were prepared by machine smoking different numbers (20 or 60) of two commercial cigarettes (Marlboro Silver or Red) under International Standardization Organization (ISO) or Health Canada Intense (HCI) smoking machine regimens and tested in the two cell lines with and without rat liver S9 activation. The S9-mediated IVMNT dose-response data from the WSSs were evaluated with PROAST software and Benchmark Doses (BMDs) and their upper and lower confidence intervals (CIs) were generated. IVMNT data differed based on the number and type of cigarettes smoked and smoking machine regimen. The IVMNT responses produced in mouse lymphoma cells generally were greater than in TK6 cells, but the ability of the two cell types to differentiate between WSSs was similar. The results indicate that BMD potency ranking was useful for differentiating between IVMNT responses., (Published by Elsevier B.V.)- Published
- 2021
- Full Text
- View/download PDF